Recombinant Human IMPDH2 Protein，His

IMPDH2 (Inosine Monophosphate Dehydrogenase 2) is a crucial enzyme involved in the de novo synthesis of purine nucleotides, playing a significant role in cellular proliferation and immune responses. Its importance is underscored by its involvement in various physiological and pathological processes, including cancer, where its overexpression can lead to uncontrolled cell growth. The interest in IMPDH2 has surged due to its potential as a therapeutic target, particularly in the development of immunosuppressive drugs for organ transplantation and treatments for autoimmune diseases. Additionally, scientists have been exploring its structure and function through recombinant protein studies to better understand its enzymatic mechanisms and interaction with potential inhibitors. The expression of recombinant IMPDH2 facilitates high-throughput screening of small molecules that may serve as effective inhibitors, ultimately aiming to provide new avenues for therapeutic interventions. Understanding the biochemistry of IMPDH2 at the molecular level can pave the way for novel drug designs and strategies to combat conditions linked with abnormal purine metabolism, making it a focal point of research in both biochemistry and pharmacology.